Standard
Certolizumab pegol for hidradenitis suppurativa : Case report and literature review. / Holm, Jesper Gronlund; Jorgensen, Astrid-Helene Ravn; Yao, Yiqiu; Thomsen, Simon Francis.
I:
Dermatologic Therapy, Bind 33, Nr. 6, 14494, 2020.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Holm, JG, Jorgensen, A-HR, Yao, Y
& Thomsen, SF 2020, '
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review',
Dermatologic Therapy, bind 33, nr. 6, 14494.
https://doi.org/10.1111/dth.14494APA
Holm, J. G., Jorgensen, A-H. R., Yao, Y.
, & Thomsen, S. F. (2020).
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.
Dermatologic Therapy,
33(6), [14494].
https://doi.org/10.1111/dth.14494Vancouver
Holm JG, Jorgensen A-HR, Yao Y
, Thomsen SF.
Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.
Dermatologic Therapy. 2020;33(6). 14494.
https://doi.org/10.1111/dth.14494Author
Holm, Jesper Gronlund ; Jorgensen, Astrid-Helene Ravn ; Yao, Yiqiu ; Thomsen, Simon Francis. / Certolizumab pegol for hidradenitis suppurativa : Case report and literature review. I: Dermatologic Therapy. 2020 ; Bind 33, Nr. 6.
Bibtex
@article{8b69f574ce664065a7b98cc0b6165582,
title = "Certolizumab pegol for hidradenitis suppurativa: Case report and literature review",
keywords = "TNF-ALPHA INHIBITORS",
author = "Holm, {Jesper Gronlund} and Jorgensen, {Astrid-Helene Ravn} and Yiqiu Yao and Thomsen, {Simon Francis}",
year = "2020",
doi = "10.1111/dth.14494",
language = "English",
volume = "33",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "6",
}
RIS
TY - JOUR
T1 - Certolizumab pegol for hidradenitis suppurativa
T2 - Case report and literature review
AU - Holm, Jesper Gronlund
AU - Jorgensen, Astrid-Helene Ravn
AU - Yao, Yiqiu
AU - Thomsen, Simon Francis
PY - 2020
Y1 - 2020
KW - TNF-ALPHA INHIBITORS
U2 - 10.1111/dth.14494
DO - 10.1111/dth.14494
M3 - Letter
C2 - 33135826
VL - 33
JO - Dermatologic Therapy
JF - Dermatologic Therapy
SN - 1396-0296
IS - 6
M1 - 14494
ER -
